SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-011799
Filing Date
2023-07-11
Accepted
2023-07-11 16:20:14
Documents
15
Period of Report
2023-07-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cydy-20230706x8k.htm   iXBRL 8-K 39850
2 EX-99.1 cydy-20230706xex99d1.htm EX-99.1 16603
3 GRAPHIC cydy-20230706xex99d1002.jpg GRAPHIC 3467
  Complete submission text file 0001558370-23-011799.txt   269024

Data Files

Seq Description Document Type Size
4 EX-101.SCH cydy-20230706.xsd EX-101.SCH 3247
5 EX-101.LAB cydy-20230706_lab.xml EX-101.LAB 632
6 EX-101.PRE cydy-20230706_pre.xml EX-101.PRE 9552
9 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20230706x8k_htm.xml XML 4261
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 231082336
SIC: 2834 Pharmaceutical Preparations